Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gem nuclear organelle associated protein 8 pseudogene 3 (GEMIN8P3) is a pseudogene, meaning it is a DNA segment highly similar to a functional gene but annotated as non-functional due to disabling mutations. Most pseudogenes like GEMIN8P3 are not translated into functional proteins and do not serve as classic therapeutic targets such as receptors, enzymes, or transporters[1][4][7]. Although pseudogenes are widely assumed to be genomic relics, some can have regulatory roles—often through RNA-based mechanisms such as acting as microRNA decoys or participating in alternative splicing or gene expression regulation—but for GEMIN8P3, no direct evidence of such a function is known at present[2][3][5][7]. It is not currently recognized as a therapeutic target and there are no drugs or biomarkers associated with it. Annotation for this gene is largely limited to its identification as a processed pseudogene derived from GEMIN8, with no established role in disease or therapeutic applications[1][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gem nuclear organelle associated protein 8 pseudogene 3 (GEMIN8P3).